Amyloid β gene vaccines
AssigneeBoard of Regents, The University of Texas System
InventorsRoger N. Rosenberg, Stephen A. Johnston, Bao-Xi Qu
Life of this patent
Estimating the term…
Abstract
The invention generally concerns compositions and methods for genetic vaccination with amyloid beta (Aβ) protein. Such vaccines may provide effective treatment for neurodegenerative disease such as Alzheimer's disease. Vaccination methods are can be used to induce a Th2 type immune response directed to Aβ. This immune response id shown to substantially reduce Aβ concentration and Aβ plaque size in an Alzheimer's model system.
Claims5
A nucleic acid encoding a fusion protein comprising the amino acid sequence of SEQ ID NO:
- 4.
A method for stimulating a Th2 immune response against an Aβ polypeptide in an animal comprising administering to the animal a nucleic acid encoding a fusion protein comprising the amino acid sequence of SEQ ID NO:
- 4, wherein the Th2 immune response against the Aβ polypeptide is stimulated.
Dependencies are inferred from the claim text.